Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

Clinical trial NCT06637163 · RECRUITING

Trial details

NCT number: NCT06637163
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2024-10-24
Primary completion: 2026-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.